Literature DB >> 3025094

Altered function of synovial fluid granulocytes in patients with acute inflammatory arthritis: evidence for activation of neutrophils and its mediation by a factor present in synovial fluid.

J G Bender, D E Van Epps, R Searles, R C Williams.   

Abstract

In rheumatoid arthritis (RA) a chronic inflammatory state exists in which the synovial fluid is periodically filled with large numbers of polymorphonuclear leukocytes (PMNs). Oxygen radicals produced by these cells have been implicated as mediators of tissue damage and may be directly involved in the pathogenesis of RA. We examined the production of oxygen radicals by synovial fluid PMNs (SF-PMNs) and peripheral blood PMNs (PB-PMNs) by measuring chemiluminescence (CL) as well as superoxide anion (O2-) release. Increased spontaneous CL in the presence of luminol and increased CL in response to phorbol myristate acetate (PMA) was observed in SF-PMNs when compared to PB-PMNs. When zymosan was used as the stimulus in the absence of luminol, a slightly lower CL response was observed in SF-PMNs as compared to PB-PMNs. No significant differences were observed in the generation of O2- generation with any stimulus. Preincubation of normal PB-PMNs in 10% synovial fluid enhanced the luminol-dependent spontaneous and PMA-stimulated CL as well as zymosan-stimulated CL. When O2- release from normal PB-PMNs pretreated with 10% synovial fluid was compared to untreated controls, enhancement of spontaneous O2- release was observed. PMA- and zymosan-stimulated responses did not differ significantly from controls. Increased spontaneous and PMA-stimulated release of myeloperoxidase (MPO) was also observed in normal PB-PMNs pretreated with synovial fluid. These findings may explain the increased luminol-dependent CL since this type of CL requires the presence of MPO. Our findings suggest that the enhanced chemiluminescence observed in normal PMNs treated with synovial fluids may be related to increases in spontaneous O2- generation and myeloperoxidase release. Increased MPO release may account for enhanced CL observed in SF-PMNs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025094     DOI: 10.1007/BF00915828

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  18 in total

1.  In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.

Authors:  P Stevens; D J Winston; K Van Dyke
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

2.  The pathogenic role of superoxide radicals in inflammation: efficacy of exogenous superoxide dismutase.

Authors:  R Beckmann; L Flohé
Journal:  Bull Eur Physiopathol Respir       Date:  1981

Review 3.  Oxidants from phagocytes: agents of defense and destruction.

Authors:  B M Babior
Journal:  Blood       Date:  1984-11       Impact factor: 22.113

4.  Metabolic and secretory properties of peripheral and synovial granulocytes in rheumatoid arthritis.

Authors:  R J van de Stadt; E van de Voorde-Vissers; T M Feltkamp-Vroom
Journal:  Arthritis Rheum       Date:  1980-01

5.  Defective phagocytosis by synovial fluid and blood polymorphonuclear leucocytes in patients with rheumatoid arthritis. I. The nature of the defect.

Authors:  J M Wilton; T Gibson; C M Chuck
Journal:  Rheumatol Rehabil       Date:  1978

6.  Free radicals and inflammation: protection of synovial fluid by superoxide dismutase.

Authors:  J M McCord
Journal:  Science       Date:  1974-08-09       Impact factor: 47.728

7.  Chemiluminescence by polymorphonuclear leukocytes from patients with active bacterial infection.

Authors:  A G Barbour; C D Allred; C O Solberg; H R Hill
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

8.  Enhancement of neutrophils function as a result of prior exposure to chemotactic factor.

Authors:  D E Van Epps; M L Garcia
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

9.  Analysis of immune complexes in synovial effusions of patients with rheumatoid arthritis.

Authors:  D Male; I M Roitt; F C Hay
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

10.  Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis.

Authors:  J Lunec; S P Halloran; A G White; T L Dormandy
Journal:  J Rheumatol       Date:  1981 Mar-Apr       Impact factor: 4.666

View more
  11 in total

1.  Characterization of arachidonic acid metabolism, superoxide production, and bacterial killing by bovine alveolar neutrophils elicited with leukotriene B4 and zymosan-activated plasma.

Authors:  J R Heidel; S M Taylor; R M Silflow; W W Laegreid; R W Leid
Journal:  Inflammation       Date:  1991-02       Impact factor: 4.092

2.  Activation of the neutrophil myeloperoxidase-H2O2 system by synovial fluid isolated from patients with rheumatoid arthritis.

Authors:  H L Nurcombe; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

3.  Neutrophil enzyme activities in carrageenan-induced inflammation in rats.

Authors:  I Sopata; E Wojtecka-Lukasik; J Wize; S Maśliński
Journal:  Agents Actions       Date:  1989-08

4.  Alterations in neutrophil superoxide production following piroxicam therapy in patients with rheumatoid arthritis.

Authors:  D E Van Epps; S Greiwe; J Potter; J Goodwin
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

5.  Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo.

Authors:  H L Nurcombe; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

6.  Activation of neutrophil reactive-oxidant production by synovial fluid from patients with inflammatory joint disease. Soluble and insoluble immunoglobulin aggregates activate different pathways in primed and unprimed cells.

Authors:  J Robinson; F Watson; R C Bucknall; S W Edwards
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

7.  Role of Fc gamma receptors in the activation of neutrophils by soluble and insoluble immunoglobulin aggregates isolated from the synovial fluid of patients with rheumatoid arthritis.

Authors:  J J Robinson; F Watson; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

8.  Inhibition of neutrophil oxidant secretion by D-penicillamine: scavenging of H2O2 and HOCl.

Authors:  M J Ledson; R C Bucknall; S W Edwards
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

9.  Bioluminescence imaging of myeloperoxidase activity in vivo.

Authors:  Shimon Gross; Seth T Gammon; Britney L Moss; Daniel Rauch; John Harding; Jay W Heinecke; Lee Ratner; David Piwnica-Worms
Journal:  Nat Med       Date:  2009-03-22       Impact factor: 53.440

10.  Lithothamnion muelleri treatment ameliorates inflammatory and hypernociceptive responses in antigen-induced arthritis in mice.

Authors:  Vivian V Costa; Flavio A Amaral; Fernanda M Coelho; Celso M Queiroz-Junior; Bruna G Malagoli; Jose Hugo S Gomes; Fernando Lopes; Kátia D Silveira; Daniela Sachs; Caio T Fagundes; Lívia D Tavares; Vanessa Pinho; Tarcilia A Silva; Mauro M Teixeira; Fernão C Braga; Danielle G Souza
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.